Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic Effects of Ketohexokinase Inhibition on Individuals With Non-alcoholic Fatty Liver Disease

NCT05463575 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT05463575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05463575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic Effects of Ketohexokinase Inhibition on Individuals With Non-alcoholic Fatty Liver Disease
Lead sponsor
Maastricht University Medical Center
Phase
Phase 2
Overall status
Completed
Start date
October 1, 2022
Completion date
November 24, 2023
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nafld